Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
gene editing
3
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
base editing
boston blog main
boston top stories
clinical study
crispr therapeutics
enzyme
2025
ad-comm
affimed
agios therapeutics
akcea therapeutics
allogene therapeutics
amicus therapeutics
approval
apremilast
bio
biogen
biome
blueprint medicineas
boston
boulder/denver blog main
boulder/denver top stories
branden moriarty
briefing docs
broad institute
car-t
cas13
celgene
cervical cancer
clinical trial
commissioner
crispr
crispr-cas9
What
therapeutics
3
×
crispr
editing
gene
medicine
allogene
beam
benefit
bio
cancer
cas
diversity
editas
editor
founders
going
gotten
harvard
hot
humans
immunotherapy
investors
ipo
isn't
jump
juno
landmark
little
mass
million
morning
nasdaq
nearly
new
phase
precise
remains
reported
reports
results
Language
Current search:
biotech
×
" gene editing "
×
therapeutics
×
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M
